| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.36 | 1e-12 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.36 | 1e-10 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.31 | 4e-10 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.37 | 5e-10 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.38 | 1e-09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-05 |